Market Research Logo

Global Epigenetics Market 2017-2021

Global Epigenetics Market 2017-2021

About Epigenetics

Epigenetics is a biological process to control gene expression by altering the chromatin structure. Genes which are going to be expressed are associated with accessible chromatin regions, whereas silent genes are often associated with inaccessible chromatin regions. Epigenetics products that include reagents, kits, enzymes, instruments, and drugs help in analyzing epigenetic changes on the basis of which epigenetic therapy develops.

Technavio’s analysts forecast the global epigenetics market to grow at a CAGR of 13.22% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global epigenetics market for 2017-2021. To calculate the market size, the report considers the revenue generated from the retail sales of epigenetics products.The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Epigenetics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Abcam
  • Bio-Rad Laboratories
  • Merck
  • Thermo Fisher Scientific
Other prominent vendors
  • Active Motif
  • BellBrook Labs
  • BioVision
  • CELGENE
  • Cisbio.com
  • Diagenode
  • Epizyme
  • Illumina
  • New England Biolabs
  • Novartis
  • QIAGEN
Market driver
  • Increasing prevalence of cancer
  • For a full, detailed list, view our report
Market challenge
  • Difficulty in finding predictive epigenetic biomarker
  • For a full, detailed list, view our report
Market trend
  • Increasing demand for personalized medicine
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Epigenetics Market 2017-2021

Technavio recognizes the following companies as the key players in the global epigenetics market: Abcam, Bio-Rad Laboratories, Merck, and Thermo Fisher Scientific.

Other Prominent Vendors in the market are: Active Motif, BellBrook Labs, BioVision, CELGENE, Cisbio.com, Diagenode, Epizyme, Illumina, New England Biolabs, Novartis, and QIAGEN.

Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is increasing demand for personalized medicine. The demand for personalized medicine is increasing and is expected to grow in future with a CAGR of more than 10%. The development of whole genome technology, companion diagnostics, and the growing number of retail clinics are some reasons for its growth.”

According to the report, one driver in the market is increasing prevalence of cancer. Epigenetic mechanisms are essential for the normal development and maintenance of tissue-specific gene expression patterns in mammals. The disruption of epigenetic processes can lead to the malicious transformation of cells and altered gene function. Alteration in the heritable epigenetic marks can result in inappropriate activation or inhibition of various signaling pathways and lead to disease states such as cancer. Cancer is one of the major public health problems globally. It is one of the leading causes of death. It was estimated that in 2012, more than 2% new cancer cases occurred globally.

Further, the report states that one challenge in the market is difficulty in finding predictive epigenetic biomarker. A biomarker is a characteristic that is accurately measured and evaluated as an indicator of normal biological processes, pharmacologic responses, or pathogenic processes to a therapeutic intervention. It is any structure, substance, or method that can be measured in the body. It can be a product such as protein after gene expression, which can predict the incidence or outcome of a disease. The use of biomarkers in clinical and basic research as well as in clinical practice has become so ordinary that their presence as primary endpoints in clinical trials is now accepted almost without question.

Companies Mentioned

Abcam, Bio-Rad Laboratories, Merck, Thermo Fisher Scientific, Active Motif, BellBrook Labs, BioVision, CELGENE, Cisbio.com, Diagenode, Epizyme, Illumina, New England Biolabs, Novartis, and QIAGEN.

  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
    • Market outline
      • Table Epigenetic changes in DNA
      • Table Normal cellular functions regulated by epigenetic mechanisms and molecular
      • Table Global epigenetics market: Market overview
  • Market landscape
    • Market size and forecast
      • Table Global epigenetics market 2016-2021 ($ billions)
      • Table Factors impacting global epigenetics market
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by product
    • Global epigenetics market by product
      • Table Global epigenetics market by product 2016-2021 (% share)
      • Table Global epigenetics market by product: Snapshot
    • Global epigenetics market by reagents
      • Table Global epigenetics market by reagents 2016-2021 ($ billions)
    • Global epigenetics market by kits
      • Table Global epigenetic market by kits 2016-2021 ($ billions)
    • Global epigenetics market by others
      • Table Global epigenetic market by others 2016-2021 ($ billions)
  • Geographical segmentation
    • Global epigenetics market by geography
      • Table Global epigenetics market by geography 2016-2021 (% share)
      • Table Global epigenetics market by geography: Snapshot
    • Epigenetics market in Americas
      • Table Epigenetics market in Americas 2016-2021 ($ billions)
    • Epigenetics market in EMEA
      • Table Epigenetics market in EMEA 2016-2021 ($ billions)
    • Epigenetics market in APAC
      • Table Epigenetics market in APAC 2016-2021 ($ billions)
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
  • Market trends
    • Increasing use of epigenetics as a tool to understand development and disease
    • Increasing demand for personalized medicine
    • Rise in investment in R&D
  • Vendor landscape
    • Competitive scenario
      • Table Competitive parameters in global epigenetics market
    • Investment opportunity analysis
      • Table Investment opportunity mapping
      • Table Strategic success factors for companies
  • Key vendor analysis
    • Abcam
      • Table Abcam: Company profile
      • Table Abcam: Strength analysis
      • Table Abcam: Strategy assessment
      • Table Abcam: Opportunity assessment
    • Bio-Rad Laboratories
      • Table Bio-Rad Laboratories: Company profile
      • Table Bio-Rad Laboratories: Strength analysis
      • Table Bio-Rad Laboratories: Strategy assessment
      • Table Bio-Rad Laboratories: Opportunity assessment
    • Merck
      • Table Merck: Company profile
      • Table Merck: Strength analysis
      • Table Merck: Strategy assessment
      • Table Merck: Opportunity assessment
    • Thermo Fisher Scientific
      • Table Thermo Fisher Scientific: Company profile
      • Table Thermo Fisher Scientific: Strength analysis
      • Table Thermo Fisher Scientific: Strategy assessment
      • Table Thermo Fisher Scientific: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report